JAMDA
Volume 11, Issue 1 , Pages 26-32, January 2010

ACE-Inhibition and Physical Function: Results From the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) Study

  • Matteo Cesari, MD, PhD

      Affiliations

    • Centro per la Salute dell'Anziano–Area di Geriatria, Università Campus Bio-Medico, Rome, Italy
    • Fondazione “Alberto Sordi,” Università Campus Bio-Medico, Rome, Italy
    • Department of Aging and Geriatric Research, University of Florida, Institute on Aging, Gainesville, FL
    • Corresponding Author InformationAddress correspondence to Matteo Cesari, MD, PhD, Centro per la Salute dell'Anziano–Area di Geriatria, Università Campus Bio-Medico, Via Alvaro del Portillo 5, 00128 Rome, Italy.
  • ,
  • Claudio Pedone, MD, PhD, MPH

      Affiliations

    • Centro per la Salute dell'Anziano–Area di Geriatria, Università Campus Bio-Medico, Rome, Italy
    • Fondazione “Alberto Sordi,” Università Campus Bio-Medico, Rome, Italy
  • ,
  • Raffaele Antonelli Incalzi, MD, PhD

      Affiliations

    • Centro per la Salute dell'Anziano–Area di Geriatria, Università Campus Bio-Medico, Rome, Italy
    • Fondazione “Alberto Sordi,” Università Campus Bio-Medico, Rome, Italy
  • ,
  • Marco Pahor, MD

      Affiliations

    • Department of Aging and Geriatric Research, University of Florida, Institute on Aging, Gainesville, FL

published online 26 November 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The TRAIN study was funded by the National Institutes of Health (NIH grant R01-HL68901). The TRAIN study was also (partially) supported by the University of Florida Claude D. Pepper Older Americans Independence Center (NIH grant 1P30-AG028740), Wake Forest University Claude D. Pepper Older Americans Independence Center (NIH grant 5P30-AG021332), and the Wake Forest University General Clinical Research Center (NIH grant M01-RR07122). Fosinopril was donated by Bristol-Myers Squibb (New York, NY).

PII: S1525-8610(09)00347-8

doi:10.1016/j.jamda.2009.09.014

JAMDA
Volume 11, Issue 1 , Pages 26-32, January 2010